Abeona Therapeutics (ABEO) Tops Q3 EPS by 5c

Abeona Therapeutics (NASDAQ: ABEO) reported Q3 EPS of ($0.48), $0.05 better than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Abeona Therapeutics (ABEO) click here.

You May Also Be Interested In

• SanDisk stock target lifted by Citi on continued demand strength
• SYNNEX Corp. (SNX) Tops Q2 EPS by 74c, Beats on Revenue; Offers Q3 Guidance
• onsemi to acquire Synaptics in $7 billion all-stock deal